| 发明名称 | HIG2 and URLC10 epitope peptide and vaccines containing the same | ||
| 摘要 | The present invention provides a pharmaceutical agent or composition containing one or more peptides having the amino acid sequence of SEQ ID NO: 1 or 2, or one or more polynucleotides encoding such a peptide formulated for the treatment and/or prevention of cancer in a subject whose HLA-A antigen is HLA-A0206. Furthermore, the present invention provides a method of inducing CTL and antigen-presenting cells using such peptides, polynucleotides or pharmaceutical agents. | ||
| 申请公布号 | US9119800(B2) | 申请公布日期 | 2015.09.01 |
| 申请号 | US200913059618 | 申请日期 | 2009.08.14 |
| 申请人 | OncoTherapy Science, Inc. | 发明人 | Tsunoda Takuya;Ohsawa Ryuji;Yoshimura Sachiko |
| 分类号 | A61K39/385;A61K39/00;C07K14/725;A61K38/00 | 主分类号 | A61K39/385 |
| 代理机构 | Kilpatrick Townsend & Stockton LLP | 代理人 | Kilpatrick Townsend & Stockton LLP |
| 主权项 | 1. A method for inducing an antigen-presenting cell with high CTL inducibility, wherein the method comprises the steps of a) collecting APCs from a subject whose HLA-A antigen is HLA-A0206, and b) contacting the APCs of step a with a peptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NO: 1 and 2. | ||
| 地址 | Kanagawa JP | ||